Mark Christianson, Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), sold 917 shares at $0.80 ($734) on 2026-03-12, disclosed to the SEC on 2026-03-16.
Open-market sale of $734 NMTC by Business Development Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.80 | 817 | $654 | 89.1% |
| 2 | $0.80 | 100 | $80 | 10.9% |
| Total | $0.80 avg | 917 | $734 | 100% |
| Filing → |
| NMTC | SELL | 2026-03-12 | $11K | — | Filing → |
| NMTC | SELL | 2025-09-09 | $22K | — | Filing → |
| NMTC | SELL | 2025-06-05 | $6K | — | Filing → |